Immunologic function and survival in hemodialysis patients

Kidney International

Volumn 54, Issue 1, 1998, Pages 236-244

  Kimmel, Paul L ^a   Phillips, Terry M ^b   Simmens, Samuel J ^b   Peterson, Rolf A ^b   Weihs, Karen L ^b   Alleyne, Sylvan ^b   Cruz, Illuminado ^b   Yanovski, Jack A ^b   Veis, Judith H ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NONE

Author keywords

Chronic kidney; Cytokine; Dialyzer; Failure; Hemodialysis; Interleukin; Survival; T cell; Tumor necrosis factor

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLOOD LEVEL; CLINICAL TRIAL; COMORBIDITY; DEMOGRAPHY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOREACTIVITY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION;

EID: 0031835451     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00981.x     Document Type: Article

References (37)

1. HELD PJ, PORT FK, WEBB RL, ET AL: Excerpts from the United States Renal Data System 1996 Annual Report. Am J Kidney Dis 28(Suppl): S79-S92, 1996
2. OWEN WF JR, LEW NL, LIU Y, LOWRIE EG, LAZARUS JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
3. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
4. LOWRIE EG, LAIRD M, PARKER TF, SARGENT JA: The effect of hemodialysis prescription on patient mortality. Report from the NCDS. N Engl J Med 32:382-389, 1981
5. HELD PJ, PORT FK, WOLFE RA, STANNARD DC, CARROLL CE, DAUGIRDAS JT, BLOEMBERGEN WE, GREER JW, HAKIM RM: The dose of hemodialysis and patient mortality. Kidney Int 50:550-556, 1996
6. HAKIM RM, BREYER J, ISMAIL N. SCHULMAN G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23:661-669, 1994
7. HAKIM RM, HELD PJ, STANNARD DC, WOLFE RA, PORT FK, DAUGIRDAS JT, AGODOA L: Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 50:566-570, 1996
8. RASKA K, RASKOVA J, SHEA SM, FRANKEL RM, WOOD RH, LIFTER J, GHOBRIAL I, EISINGER RP, HOMER L: T cell subsets and cellular immunity in end-stage renal disease. Am J Med 75:734-740, 1983
9. KIMMEL PL, PHILLIPS TM, PHILLIPS E, BOSCH JP: The effect of renal replacement therapy of cellular cytokine production in patients with renal disease. Kidney Int 38:129-135, 1990
10. DINARELLO CA: Cytokines: Agents provacateurs in hemodialysis? Kidney Int 41:683-694, 1992
11. KAY NE, RAIJ LR: Immune abnormalities in renal failure and hemodialysis. Blood Purif 4:120-129, 1986
12. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR: Mini-mental state: A practical method for grading the cognitive states of patients for the clinician. J Psych Res 12:189-198, 1975
13. PLOUGH AL, SHWARTZ M, SALEM SR, WELLER JM, FERGUSON CW: Severity analysis in end stage renal disease: A risk group approach. Am Soc Artif Intern Org J 8:33-40, 1985
14. JINDAL JK, MANUEL A, GOLDSTEIN MB: Percent reduction in blood urea concentration during hemodialysis. Trans Am Soc Artif Intern Organs 33:286-288, 1987
15. DURNIN JVGA, WOMERSLEY J: Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-96, 1974
16. HEYMSFIELD SB, MCMANUS C, SMITH J, STEVENS V, NIXON DW: Anthropometric measurement of muscle mass: Revised equations for calculating bone-free arm muscle area. Am J Clin Nutr 36:680-690, 1982
17. KIMMEL PL, PETERSON RA, WEIHS KL, SIMMENS SJ, BOYLE DH, VERME D, UMANA WO, VEIS JH, ALLEYNE S, CRUZ I: Behavioral compliance with dialysis prescription in hemodialysis patients. J Am Soc Nephrol 5:1826-1834, 1995
18. SCHELLEKENS P, EIJSVOOGOZ VP: Lymphocyte transformation in vitro. I. Tissue culture conditions and qualitative measurement. Clin Exp Immunol 3:571-578, 1968
19. PHILLIPS TM: Analytical Techniques in Immunochemistry. New York, Marcel Dekker, 1992, pp 195-196, 281-283
20. PHILLIPS TM: High performance capillary electrophoresis analysis of tissue cytokines. LC.GC 11:36-42, 1993
21. PHILLIPS TM, KIMMEL PL: High performance capillary electrophoresis analysis inflammatory citokines in human biopsies. J Chromatog Biomed Appl 656:259-266, 1994
22. THORPE GHG, BRONSTEIN I, KRICKA LJ, EDWARDS B, VOYTA JC: Chemiluminescent enzyme immunoassay of α-fetoprotein based on an adamentyl dioetane phenyl phosphate substrate, Clin Chem 35:2319-2321, 1989
23. LEE EL: Statistical Methods for Survival Data Analysis (2nd ed). New York, Wiley, 1992, pp 250-263
24. HOSMER D, LEMESHOW S: Applied logistic regression, in Statistical Methods for Survival Data Analysis (2nd ed). New York, John Wiley & Sons, Inc., 1989, pp 56-57
25. HENDERSON LW, KOCH KM, DINARELLO CA, SHALDON S: Hemodialysis hypotension: The interleukin hypothesis. Blood Purif 1:3-8, 1983
26. IKIZLER TA, HAKIM RM: Nutrition in end-stage renal disease. Kidney Int 50:343-357, 1996
27. NELSON EE, CHANGGI DH, PESCE AL, PETERSON DW, SINGH S, POLLACK VE: Anthropometric norms for the dialysis population. Am J Kidney Dis 16:32-37, 1990
28. VILCEK J, LE J: Immunology of cytokines: An introduction, in The Cytokine Handbook (2nd ed), edited by THOMSON A, London, Academic Press Ltd, 1994, pp 1-19
29. KIMMEL PL, PHILLIPS TM, LEW SQ, LANGMAN CB: Zinc modulates mononuclear cell calcitriol metabolism in peritoneal dialysis patients. Kidney Int 49:1407-1412, 1996
30. HERTEL J, KIMMEL PL, PHILLIPS TM, BOSCH JP: Eosinophilia and cellular cytokine responsiveness in hemodialysis patients. J Am Soc Nephrol 3:1244-1252, 1992
31. FISHER CJ JR, AGOSTI JM, OPAL SM, LOWRY SF, BALK RA, SADOFF JC, ABRAHAM E, SCHEIN RMH, BENJAMIN E: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 334:1697-1702, 1996
32. GIRNDT M, KOHLER H, SCHIEDHEIM-WEICK E, SCHLAAK JF, ZUM BUSCHENFELDE K-HM, FLEISCHER B: Production of interleukin-6. tumor necrosis factor-α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47:559-565, 1995
33. MITCH WE, GOLDBERG AL: Mechanisms of muscle wasting: The role of the ubiquitin-proteasome pathway. N Engl J Med 335:1897-1905, 1996
34. BANCHEREAU J, RYBACK ME: Interleukin 4, in The Cytokine Handbook (2nd ed), edited by THOMSON A, London, Academic Press Ltd, 1994, pp 99-126
35. WEILER JM: Introduction, in Complement in Health and Disease (vol 20), Immunology and Medicine, edited by WHALEY K, Loos M, WEILER JM, Hingham, Kluwer Academic Publishers, 1993, pp 1-37
36. PEREIRA BJG, SNODGRASS BR, HOGAN PJ, KING AJ: Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 47:603-610, 1995
37. PEREIRA BJG, SHAPIRO L, KING AJ, FALAGAS ME, STROM JA, DINARELLO CA: Plasma levels of IL-1 beta, TNF-alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1994